ANTI-COAGULANT THERAPY IN HOSPITALIZED PREGNANT WOMEN WITH COVID-19: A BRIEF REVIEW

Authors

  • Asma Ambareen Department of Obs & Gynae KMC / MTI KTH , Peshawar
  • Arash Timadi Division of Medicine, Royal Sohar Hospital, Sultanate of Oman.
  • Tayyaba Mazhar Department of Obs & Gynae KMC / MTI KTH , Peshawar
  • Arshad Javed Division of Medicine, Royal Sohar Hospital, Sultanate of Oman.
  • Shakir Zaman Physician NHS, UK
  • Sami Ullah Medicine B Ward, DHQ Hospital KDA, Kohat.

DOI:

https://doi.org/10.33279/jkcd.v11i03.128

Keywords:

COVID-19, Pregnancy, Prothrombotic state, Venous thromboembolism (VTE), COVID-19associated coagulopathy, Thromboprophylaxis

Abstract

As our knowledge about COVID-19 progresses, we know that COVID-19 has a clear thrombogenic effect. Moreover, as pregnancy is a prothrombotic state, the possibility of an increased risk of venous thromboembolism (VTE) in pregnant women with COVID‐19 has become an area of concern, and a number of international organizations have proposed recommendations for thromboprophylaxis in pregnant and postpartum women with COVID‐19. However, these recommendations are mainly based on expert opinion. In this brief review, we explain the pathophysiology of COVID-19- associated coagulopathy with focus on pregnancy related issues, leading to make clear recommendations about anti-coagulant therapy in pregnant women with COVID-19 during hospitalization and also after discharge.

Downloads

Published

2021-09-30

How to Cite

Asma Ambareen, Arash Timadi, Tayyaba Mazhar, Arshad Javed, Shakir Zaman, & Sami Ullah. (2021). ANTI-COAGULANT THERAPY IN HOSPITALIZED PREGNANT WOMEN WITH COVID-19: A BRIEF REVIEW. JOURNAL OF KHYBER COLLEGE OF DENTISTRY, 11(03), 21–24. https://doi.org/10.33279/jkcd.v11i03.128

Issue

Vol. 11 No. 03 (2021): Journal of Khyber College of Dentistry

Section

Original Article

License

Copyright (c) 2021 Asma Ambareen, Arash Timadi, Tayyaba Mazhar, Arshad Javed, Shakir Zaman, Sami Ullah

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. Adapt — remix, transform, and build upon the material
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.